In addition, in vivo stimulation of iNKT cells with alpha-GalCer induces a potent anti-tumor immune response [8], [9] that is thought to be mediated through their production of IFNgamma, thereby promoting the antitumor functions of NK and CD8+ T cells [2], [10], [11]. The gene discussed is CD8A; the disease is neoplasm.